Tag: Alzheimer’s
Alzheimer Disease, Related Dementia Diagnoses Up in Medicare Decedents
Percentage of older U.S. decedents with a diagnosis of Alzheimer disease and related dementias increased significantly from 2004 to 2017
Excess Mortality Seen for Seniors With Alzheimer Disease, Dementia in COVID-19
Enrollees with ADRD had increased adjusted mortality, especially for Asian, Black, Hispanic populations with ADRD
Neuroimaging Measures Linked to Stages of Memory Impairment
Presence of Alzheimer disease pathology related to Stages of Objective Memory Impairment in cognitively unimpaired older adults
AAN Issues Review of Evidence for Aducanumab in Alzheimer Disease
Class I study shows single doses of aducanumab safe, well tolerated; class II studies show reduced amyloid deposition on brain PET at one year
AAN: Higher Fitness Level Tied to Lower Alzheimer Disease Risk
Graded association seen between levels of cardiorespiratory fitness and incident Alzheimer disease and related disorders
Few Older Adults Knowledgeable About Aducanumab for Alzheimer Disease
Less than one-quarter of older adults report they would want to take it
Mental Disorders Tied to Subsequent Dementia Onset
Associations consistent across different psychiatric conditions, for Alzheimer disease and all other dementias
Medicare May Rethink Premium Hike for Pricey Alzheimer Drug
Announcement comes shortly after Aduhelm maker Biogen cut the price of the drug by about half, from $56,000 to $28,000 a year
SAGE Detects Conversion From MCI to Dementia Early
The Self-Administered Gerocognitive Examination detects the conversion from mild cognitive impairment to dementia sooner than the MMSE
Biogen Cuts Price of Controversial Aduhelm in Half
Drug shows promise in clearing brain plaques believed to play a role in Alzheimer disease
